Table III.
Summary of RMSD100
| βRMSD100 (Å) | μRMSD100 (Å) | π5 (%) | |||||||
|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||
| Target | E | P | N | E | P | N | E | P | N |
| 1OED | 1.88 | 3.69 | 3.70 | 2.08 | 3.85 | 3.89 | 13.47 | 3.80 | 4.28 |
| 1OKC | 10.93 | 11.73 | 11.75 | 11.85 | 12.25 | 12.05 | 0 | 0 | 0 |
| 1PV6 | 4.34 | 4.14 | 5.09 | 4.92 | 4.72 | 5.49 | 0.16 | 0.16 | 0 |
| 1PY6 | 3.13 | 3.40 | 4.20 | 3.99 | 4.38 | 4.70 | 0.63 | 0.35 | 0.22 |
| 1U19 | 3.83 | 4.44 | 5.10 | 5.17 | 5.42 | 5.80 | 0.07 | 0.04 | 0 |
| 2BL2 | 2.14 | 2.36 | 2.77 | 2.25 | 2.84 | 2.86 | 11.99 | 8.14 | 13.67 |
| 2K73 | 3.01 | 3.59 | 3.82 | 3.06 | 3.72 | 4.03 | 32.44 | 10.76 | 7.07 |
| 2O9G | 10.42 | 12.21 | 11.41 | 12.60 | 12.72 | 12.41 | 0 | 0 | 0 |
| 2Y01 | 4.94 | 5.06 | 5.26 | 5.21 | 5.46 | 5.76 | 0.04 | 0 | 0 |
| 3M71 | 5.63 | 5.75 | 5.94 | 6.05 | 6.26 | 6.36 | 0 | 0 | 0 |
| 3QAP | 3.33 | 3.89 | 4.26 | 4.25 | 4.50 | 4.65 | 0.56 | 0.39 | 0.3 |
| 3UG9 | 3.36 | 3.24 | 4.57 | 3.76 | 4.19 | 4.83 | 1.54 | 0.77 | 0.28 |
| 3UON | 3.70 | 4.94 | 5.30 | 5.17 | 5.30 | 5.81 | 0.13 | 0.02 | 0 |
| 4A2N | 3.51 | 3.56 | 4.30 | 3.94 | 3.79 | 4.58 | 1.28 | 1.53 | 0.55 |
| 4O6Y | 2.71 | 4.21 | 3.59 | 3.36 | 4.90 | 4.04 | 1.04 | 0.07 | 0.45 |
|
| |||||||||
| Mean | 4.46 | 5.08 | 5.40 | 5.18 | 5.62 | 5.82 | 4.22 | 1.74 | 1.79 |
E: contact numbers computed using experimental structure; P: contact numbers predicted by neural network; N: no contact numbers; μRMSD100 improved by 0.5 Å or more (bold), 0.0–0.5 Å (italic), and no improvement (normal) when folded with predicted CNs.